Bonesupport Holding AB (publ) (FRA:2B4)

Market Cap	1.96B +27.0%
Revenue (ttm)	123.60M +25.2%
Net Income	23.97M +78.9%
EPS	0.37 +79.0%
Shares Out	n/a
PE Ratio	79.44
Forward PE	46.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	325
Open	28.26
Previous Close	27.40
Day's Range	28.26 - 29.10
52-Week Range	15.50 - 29.10
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone gra...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 171
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2B4

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 26, 2026

Data Sources Report a data error